ReviewCureus2026
Semaglutide and Follow-On Peptide Therapeutics: Balancing Innovation, Regulation, and Clinical Outcomes.
Brij Teli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewCureus2026
Brij Teli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.